Neuroinflammation and the genetics of Alzheimer's disease: The search for a pro-inflammatory phenotype

Aging Clinical and Experimental Research

Volumn 13, Issue 3, 2001, Pages 163-170

  Franceschi, C ^a,b   Valensin, S ^a   Lescai, F ^a   Olivieri, F ^b   Licastro, F ^a   Grimaldi, L M E ^c   Monti, D ^d   De Benedictis, G ^e   Bonafe M ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b INRCA   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

^e UNIVERSITY OF CALABRIA   (Italy)

Author keywords

Aging; Alzheimer's disease; Genetics of AD; Inflamm aging; Neuroinflammation; Pro inflammatory phenotype

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; INTERLEUKIN 1; INTERLEUKIN 6; MITOCHONDRIAL DNA; PRESENILIN 1; PRESENILIN 2;

AGE; AGED; AGING; ALZHEIMER DISEASE; ENCEPHALITIS; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; MOLECULAR GENETICS; PATHOGENESIS; PATHOLOGY; PHENOTYPE; REVIEW; RISK ASSESSMENT;

AGED; AGING; ALZHEIMER DISEASE; CYTOKINES; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1; INTERLEUKIN-6; MIDDLE AGED; NEURITIS; PHENOTYPE;

EID: 0034962808     PISSN: 03949532     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03351475     Document Type: Review

References (46)

1. Genes. models and Alzheimer's disease
2. Inflammation and Alzheimer disease
3. Alzheimer's disease: Genes, proteins, and therapy
4. Do men and women follow different trajectories to reach extreme longevity?
5. Mitochondrial DNA haplogroups and ApoE4 allele are non independent variables in sporadic Alzheimer's disease
6. Mitochondrial involvement in Alzheimer's disease
7. Human mtDNA haplogroups associated with high or reduced spermatozoa motility
8. Mitochondrial disease in mouse results in increased oxidative stress
9. Alzheimer disease: An inflammatory disease?
10. Prevalence and severity of dementia among northern Italian centenarians
11. Inflamm-aging: An evolutionary perspective of immunosenescence
12. The network and the remodelling theories of aging
13. Biomarkers of immunosenescence within an evolutionary perspective: The challenge of heterogeneity and the role of antigenic load
14. Human immunosenescence: The prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space
15. Pro-opiomelanocortin-derived peptides, cytokines and nitric oxide in immune responses and stress: An evolutionary approach
16. The invertebrate phagocytic immunocyte: Clues to a common evolution of the immune and the endocrine systems
17. Inflammation in Alzheimer's disease: A view from the periphery
18. Increased cytokine production in mononuclear cells of healthy elderly people
19. Aging and proinflammatory cytokines
20. Appearance of biomarkers of in vitro ageing after successive stimulation of WI-38 fibroblasts with IL-1α and TNF-β: Senescence associated β-galactosidase activity and morphotype transition
21. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty
22. Lipoprotein(a) and lipoprotein profile in healthy centenarians: A reappraisal of vascular risk factors
23. Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation
24. IL-6 is an Antiinflammatory Cytokine Required for Controlling Local or Systemic Acute Inflammatory Responses
25. Increase of interleukin 6 and decrease of interleukin 2 production during the ageing process are influenced by the health status
26. The influence of age and gender on serum dehydroepiandrosterone sulphate (DHEA-S), IL-6, IL-6 soluble receptor (IL-6 sR) and transforming growth factor β1 (TGF-β1) levels in normal healthy blood donors
27. Serum IL-6 level and the development of disability in older persons
28. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
29. Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus
30. Atherosclerosis-an inflammatory disease
31. The pervasiveness of interleukin-1 in Alzheimer pathogenesis: A role for specific polymorphisms in disease risk
32. Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices
33. Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients
34. Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients
35. A role for ApoE in regulating the levels of alpha-1-antichymotrypsin in the aging mouse brain and in Alzheimer's disease
36. Association of early-onset Alzheimer's disease with an interleukin-1α gene polymorphism
37. Association of interleukin-1 gene polymorphisms with Alzheimer's disease
38. Confirmation of the genetic association of interleukin-1A with early onset sporadic Alzheimer's disease
39. Association of an interleukin-1 alpha polymorphism with Alzheimer's disease
40. Gene polymorphism affecting alpha1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk
41. Genetic polymorphisms in the cathespin D and interleukin-6 genes and the risk of Alzheimer's disease
42. Genetic polymorphism of cathepsin D is strongly associated with the risk for developing sporadic Alzheimer's disease
43. Association between an interleukin-6 promoter and 3′ flanking region haplotype and reduced Alzheimer's disease risk in a German population
44. The genetic predisposition to produce high levels of IL-6 is a detrimental gender-specific factor for longevity
45. Patients with Alzheimer's disease display a pro-inflammatory phenotype
46. Inflammation of the brain in Alzheimer's disease: Implications for therapy